#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	2324	16S	1529	1529	100.0	16S.l6.c30.ctg.1	2526	261.7	1	SNP	n	C1184T	0	.	.	1184	1184	C	1974	1974	C	330	C,A,T	268,1,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	2324	16S	1529	1529	100.0	16S.l6.c30.ctg.1	2526	261.7	0	HET	.	.	.	C83CTCGGGTG	.	83	83	C	873	873	C	362	CTCGGGTG,C	255,78	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	2324	16S	1529	1529	100.0	16S.l6.c30.ctg.1	2526	261.7	0	HET	.	.	.	T84TCGGGTGGCG,TCG	.	84	84	T	874	874	T	360	TCGGGTGGCG,TCG	249,84	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	2324	16S	1529	1529	100.0	16S.l6.c30.ctg.1	2526	261.7	0	HET	.	.	.	C207T	.	207	207	C	997	997	C	345	C,T	149,133	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	2324	16S	1529	1529	100.0	16S.l6.c30.ctg.1	2526	261.7	0	HET	.	.	.	C1450T	.	1450	1450	C	2240	2240	C	303	C,T	152,117	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	2324	16S	1529	1529	100.0	16S.l6.c30.ctg.1	2526	261.7	0	HET	.	.	.	C451T	.	451	451	C	1241	1241	C	352	C,T	154,140	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	3766	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4092	275.7	0	.	n	.	0	T695C	SNP	695	695	T	1319	1319	C	290	C,G	240,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	3766	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4092	275.7	0	.	n	.	0	T1971C	SNP	1971	1971	T	2595	2595	C	323	C,A	275,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	3766	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4092	275.7	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	3221	3221	T	299	T	249	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	3766	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4092	275.7	1	SNP	n	A2045G	0	.	.	2045	2045	A	2669	2669	A	332	A	274	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	428	folP	855	855	100.0	folP.l15.c4.ctg.1	2047	62.4	1	SNP	p	R229S	1	.	.	685	687	AGC	1268	1270	AGC	95;96;95	A;G;C	83;85;82	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1014	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3675	82.0	1	SNP	p	S91F	1	.	.	271	273	TTC	715	717	TTC	96;96;97	T;T;C	80;81;81	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1014	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3675	82.0	1	SNP	p	D95G	1	.	.	283	285	GGC	727	729	GGC	95;95;95	G;G;C	81;80;81	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1014	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3675	82.0	1	SNP	p	G95N	0	.	.	283	285	GGC	727	729	GGC	95;95;95	G;G;C	81;80;81	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	27	406	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1716	70.7	1	SNP	p	G45D	0	.	.	133	135	GGC	634	636	GGC	100;98;98	G;G,T;C	87;88,1;87	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	244	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1362	53.6	0	.	n	.	0	A197.	DEL	197	197	A	821	821	A	95	A	83	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	908	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3393	80.3	1	SNP	p	D86N	0	.	.	256	258	GAC	856	858	GAC	108;107;109	G;A;C	84;83;89	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	908	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3393	80.3	1	SNP	p	R87I	0	.	.	259	261	CGT	859	861	CGT	109;110;110	C;G;T	89;89;85	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	908	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3393	80.3	1	SNP	p	R87W	0	.	.	259	261	CGT	859	861	CGT	109;110;110	C;G;T	89;89;85	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	908	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3393	80.3	1	SNP	p	S87R	1	.	.	259	261	CGT	859	861	CGT	109;110;110	C;G;T	89;89;85	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	908	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3393	80.3	1	SNP	p	S88P	0	.	.	262	264	TCC	862	864	TCC	110;110;110	T,C;C;C	88,1;90;88	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	732	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3137	70.0	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1820	1822	GGC	97;97;98	G;G;C,T	84;77;79,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	652	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2622	73.9	1	SNP	p	A311V	0	.	.	931	933	GCC	1332	1334	GCC	86;85;85	G;C,A;C	71;70,1;72	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	652	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2622	73.9	1	SNP	p	I312M	1	.	.	934	936	ATG	1335	1337	ATG	85;85;86	A;T,A;G	75;74,1;74	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	652	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2622	73.9	1	SNP	p	V316T	1	.	.	946	948	ACC	1347	1349	ACC	88;88;87	A;C;C	75;78;74	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	652	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2622	73.9	1	SNP	p	T316P	0	.	.	946	948	ACC	1347	1349	ACC	88;88;87	A;C;C	75;78;74	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	652	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2622	73.9	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1848	1850	ACC	84;84;84	A;C,A;C,A	69;69,2;69,1	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	652	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2622	73.9	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1902	1904	GCG	83;82;82	G;C;G	65;64;66	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	652	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2622	73.9	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1902	1904	GCG	83;82;82	G;C;G	65;64;66	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	652	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2622	73.9	1	SNP	p	G542S	0	.	.	1624	1626	GGT	2025	2027	GGT	91;91;91	G;G;T	78;76;77	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	652	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2622	73.9	1	SNP	p	G545S	1	.	.	1633	1635	AGC	2034	2036	AGC	88;88;88	A;G;C	74;73;77	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	652	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2622	73.9	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2052	2054	CCG	83;83;83	C;C;G	67;71;70	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	932	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3247	85.3	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1690	1692	CCG	97;98;98	C;C;G	73;77;76	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	492	porA	1146	1146	99.91	porA.l6.c4.ctg.1	2184	67.2	0	.	p	.	0	M83fs	FSHIFT	247	247	A	761	761	C	77	C	65	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	484	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1787	79.6	0	.	p	.	0	R144Q	NONSYN	430	432	CGG	898	900	CAG	112;112;112	C,A;A,G;G	85,1;89,1;88	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	484	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1787	79.6	0	.	p	.	0	G210R	NONSYN	628	630	GGA	1096	1098	AGA	98;98;98	A;G;A	83;82;79	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	484	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1787	79.6	0	.	p	.	0	S217G	NONSYN	649	651	AGT	1117	1119	GGT	100;101;102	G;G;T	81;82;81	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	484	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1787	79.6	1	SNP	p	G120K	1	.	.	358	360	AAG	826	828	AAG	112;113;112	A;A;G	86;85;86	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	484	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1787	79.6	1	SNP	p	A121N	1	.	.	361	363	AAC	829	831	AAC	112;113;113	A,G;A;C	79,2;88;86	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	484	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1787	79.6	1	SNP	p	N121D	0	.	.	361	363	AAC	829	831	AAC	112;113;113	A,G;A;C	79,2;88;86	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	1692	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5362	94.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	244	rpsJ	312	312	100.0	rpsJ.l15.c17.ctg.1	1253	57.9	1	SNP	p	V57M	1	.	.	169	171	ATG	655	657	ATG	85;86;86	A;T;G	74;75;73	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
